Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05649904

AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis

Led by Ohio State University · Updated on 2025-04-01

240

Participants Needed

1

Research Sites

151 weeks

Total Duration

On this page

Sponsors

O

Ohio State University

Lead Sponsor

I

IRRAS

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to evaluate efficacy and safety of evacuation of cerebrospinal fluid, blood, and harmful bacteria from the intraventricular, subdural and subarachnoid spaces by Active Controlled Irrigation and Drainage (IRRAflow) compared to Passive External Ventricular Drainage (EVD). Subjects with intraventricular hemorrhage, subarachnoid hemorrhage, subdural bleeding, and ventriculitis will be randomized to receive the IRRAflow device or EVD device and followed for one month post-procedure to compare outcomes between the subject groups.

CONDITIONS

Official Title

AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Need for drainage due to intraventricular hemorrhage, intracranial hemorrhage, subarachnoid hemorrhage, chronic subdural hematoma, or ventriculitis
  • Indication for active treatment of the above conditions as evaluated by treating physician
  • Signed informed consent by the subject or legally authorized representative
Not Eligible

You will not qualify if you...

  • Fixed and dilated pupils
  • Pregnant women
  • Presence of Moyamoya disease
  • History or presence of clotting disorders
  • Platelet count below 100,000 or INR greater than 1.4

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States, 43210

Actively Recruiting

Loading map...

Research Team

E

Edouard Beliaire

CONTACT

P

Patrick Youssef, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here